ArticleExperimental neurology2025

Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney disease.

Harpreet Kaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.